TY - JOUR
T1 - Phenotype of the accessory cell necessary for mitogen-stimulated T and B cell responses in human peripheral blood
T2 - Delineation by its sensitivity to the lysosomotropic agent, L-leucine methyl ester
AU - Thiele, Dwain L
AU - Kurosaka, M.
AU - Lipsky, P. E.
PY - 1983/12/1
Y1 - 1983/12/1
N2 - The lysosomotropic compound L-leucine methyl ester (Leu-OMe) was utilized to delineate the phenotype of the accessory cells involved in human B and T cell activation in vitro. Leu-OMe was shown to cause lysosomal disruption and selective death of human monocytes (Mφ). After 30-45 minute incubations with this agent, human peripheral blood mononuclear cells (PBM) were nearly completely depleted of Mφ. Associated with this Mφ depletion, PBM were rendered unresponsive to a variety of T and B cell mitogens including the plant lectins phytohemagglutinin, concanavalin A, and pokeweed mitogen as well as the oxidative mitogens sodium periodate and neuraminidase plus galactose oxidase. Leu-OMe mediated loss of responsiveness was the result of a selective loss of an accessory cell necessary for each of these responses since reconstitution was accomplished by the addition of an Mφ-enriched adherent cell population. While intact adherent cells could reconstitute responsiveness, crude Mφ supernatants or highly purified human IL 1 alone were ineffective. Further identification of the Leu-OMe sensitive accessory cell indicated that it was entirely contained within the fraction of the adherent population identified by the monoclonal anti-Mφ antibody, 63D3. The mechanism by which Leu-OMe killed Mφ was dependent on the lysosomal content of these cells, since agents that altered lysosomal enzyme activity such as chloroquine or NH4Cl protected Mφ from Leu-OMe. Thus, the selective killing of Mφ by Leu-OMe appeared to relate to the characteristically rich endowment of lysosomes within these cells. These results support the conclusion that a lysosome-rich, leucine methyl ester-sensitive, intact Mφ identified by the monoclonal anti-Mφ antibody 63D3 is the circulating accessory cell required for mitogen-triggered human B and T cell activation.
AB - The lysosomotropic compound L-leucine methyl ester (Leu-OMe) was utilized to delineate the phenotype of the accessory cells involved in human B and T cell activation in vitro. Leu-OMe was shown to cause lysosomal disruption and selective death of human monocytes (Mφ). After 30-45 minute incubations with this agent, human peripheral blood mononuclear cells (PBM) were nearly completely depleted of Mφ. Associated with this Mφ depletion, PBM were rendered unresponsive to a variety of T and B cell mitogens including the plant lectins phytohemagglutinin, concanavalin A, and pokeweed mitogen as well as the oxidative mitogens sodium periodate and neuraminidase plus galactose oxidase. Leu-OMe mediated loss of responsiveness was the result of a selective loss of an accessory cell necessary for each of these responses since reconstitution was accomplished by the addition of an Mφ-enriched adherent cell population. While intact adherent cells could reconstitute responsiveness, crude Mφ supernatants or highly purified human IL 1 alone were ineffective. Further identification of the Leu-OMe sensitive accessory cell indicated that it was entirely contained within the fraction of the adherent population identified by the monoclonal anti-Mφ antibody, 63D3. The mechanism by which Leu-OMe killed Mφ was dependent on the lysosomal content of these cells, since agents that altered lysosomal enzyme activity such as chloroquine or NH4Cl protected Mφ from Leu-OMe. Thus, the selective killing of Mφ by Leu-OMe appeared to relate to the characteristically rich endowment of lysosomes within these cells. These results support the conclusion that a lysosome-rich, leucine methyl ester-sensitive, intact Mφ identified by the monoclonal anti-Mφ antibody 63D3 is the circulating accessory cell required for mitogen-triggered human B and T cell activation.
UR - http://www.scopus.com/inward/record.url?scp=0021039984&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0021039984&partnerID=8YFLogxK
M3 - Article
C2 - 6605384
AN - SCOPUS:0021039984
SN - 0022-1767
VL - 131
SP - 2282
EP - 2290
JO - Journal of Immunology
JF - Journal of Immunology
IS - 5
ER -